223 related articles for article (PubMed ID: 15888345)
1. Transgenic mouse models for the prevention of breast cancer.
Shen Q; Brown PH
Mutat Res; 2005 Aug; 576(1-2):93-110. PubMed ID: 15888345
[TBL] [Abstract][Full Text] [Related]
2. Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review).
Telang N; Katdare M
Oncol Rep; 2011 May; 25(5):1195-201. PubMed ID: 21399881
[TBL] [Abstract][Full Text] [Related]
3. Mammary tumorigenesis and metastasis in transgenic mice.
Webster MA; Muller WJ
Semin Cancer Biol; 1994 Feb; 5(1):69-76. PubMed ID: 8186390
[TBL] [Abstract][Full Text] [Related]
4. Mouse models of transforming growth factor beta impact in breast development and cancer.
Serra R; Crowley MR
Endocr Relat Cancer; 2005 Dec; 12(4):749-60. PubMed ID: 16322320
[TBL] [Abstract][Full Text] [Related]
5. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
6. Transgenic models of human cancer.
Hinrichs SH; Fontes JD; Bills ND; Schneider PD
Princess Takamatsu Symp; 1991; 22():259-74. PubMed ID: 1668887
[TBL] [Abstract][Full Text] [Related]
7. Mammary gland neoplasia: insights from transgenic mouse models.
Siegel PM; Hardy WR; Muller WJ
Bioessays; 2000 Jun; 22(6):554-63. PubMed ID: 10842309
[TBL] [Abstract][Full Text] [Related]
8. Modeling prostate cancer: a perspective on transgenic mouse models.
Jeet V; Russell PJ; Khatri A
Cancer Metastasis Rev; 2010 Mar; 29(1):123-42. PubMed ID: 20143131
[TBL] [Abstract][Full Text] [Related]
9. The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research.
Klein RD
Mutat Res; 2005 Aug; 576(1-2):111-9. PubMed ID: 15885713
[TBL] [Abstract][Full Text] [Related]
10. The origins of oncomice: a history of the first transgenic mice genetically engineered to develop cancer.
Hanahan D; Wagner EF; Palmiter RD
Genes Dev; 2007 Sep; 21(18):2258-70. PubMed ID: 17875663
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mouse models of human breast cancer.
Hutchinson JN; Muller WJ
Oncogene; 2000 Dec; 19(53):6130-7. PubMed ID: 11156526
[TBL] [Abstract][Full Text] [Related]
12. Studying drug resistance using genetically engineered mouse models for breast cancer.
Rottenberg S; Pajic M; Jonkers J
Methods Mol Biol; 2010; 596():33-45. PubMed ID: 19949919
[TBL] [Abstract][Full Text] [Related]
13. Rodent models for the study of etiology, prevention and treatment of breast cancer.
Gould MN
Semin Cancer Biol; 1995 Jun; 6(3):147-52. PubMed ID: 7495982
[TBL] [Abstract][Full Text] [Related]
14. Mouse models and breast cancer.
Robinson A
CMAJ; 1995 Oct; 153(8):1123-4. PubMed ID: 7553521
[TBL] [Abstract][Full Text] [Related]
15. Mouse models for breast cancer.
Hennighausen L
Oncogene; 2000 Feb; 19(8):966-7. PubMed ID: 10713679
[No Abstract] [Full Text] [Related]
16. Pre-clinical applications of transgenic mouse mammary cancer models.
Kavanaugh CJ; Desai KV; Calvo A; Brown PH; Couldrey C; Lubet R; Green JE
Transgenic Res; 2002 Dec; 11(6):617-33. PubMed ID: 12509137
[TBL] [Abstract][Full Text] [Related]
17. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mice as an in vivo model of lymphomagenesis.
Tarantul VZ
Int Rev Cytol; 2004; 236():123-80. PubMed ID: 15261738
[TBL] [Abstract][Full Text] [Related]
19. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
Man S; Munoz R; Kerbel RS
Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
[TBL] [Abstract][Full Text] [Related]
20. The utility of genetically altered mouse models for nutrition and cancer chemoprevention research.
Hursting SD; Nunez NP; Patel AC; Perkins SN; Lubet RA; Barrett JC
Mutat Res; 2005 Aug; 576(1-2):80-92. PubMed ID: 15990122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
